Major Breakthrough in Diabetes Research
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Major Breakthrough in Diabetes Research

NEW YORK, Aug. 11, 1995 -- Representing a major breakthrough in diabetes research, investigators at the Brigham and Women's and the Massachusetts General Hospital in Boston have identified two genes that may contribute to the disease and functionally demonstrate the ability of normal copies of these genes to correct diabetic cells in the majority of patients. This work is published Aug. 11 in the peer-reviewed journal, HUMAN GENE THERAPY.

The greater than 20-year search to identify as well as genetically correct a cellular defect of human diabetes is a joint collaboration between two Harvard investigators, virologist Dr. Fred Wang and immunologist Dr. Denise Faustman, working on Type I diabetes.

"This work shows that it is possible to use a patient's own cells and correct them and reinfuse them," Dr. Faustman said. "This has tremendous implications for patients who have recurrent disease after pancreas transplantation and for patients who are at great risk for diabetes.

"Human treatments are years off, however. The pace of research applications is directly related to available funding," explained Dr. Faustman. "If the funding were available, we could scale up and go into clinical trials, but diabetes research is less well funded than breast cancer research, for example, even though there are 14 million Americans with diabetes." In Type I diabetes, patients require insulin for life and die at early ages from the complications of poorly controlled blood sugars.


E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities